Metraipolis › archive › dc_eccbe8924c1d
Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors — Europe PMC PMID:42369076
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42369076
- DOI
- 10.1155/srat/6411721
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T00:26:34.380Z
- SHA-256 of the archived text
abf1e933d08487ce9d6f5df7c9232720e0b86dbb08f64e7d57ec46ee57913769- Stable URL of this page
https://metraipolis.com/documento/dc_eccbe8924c1d
How to cite
Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors — Europe PMC PMID:42369076 — Europe PMC (en), https://europepmc.org/article/MED/42369076 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eccbe8924c1d (Metraipolis archive dc_eccbe8924c1d, sha256 abf1e933d08487ce9d6f5df7c9232720e0b86dbb08f64e7d57ec46ee57913769)
BibTeX
@misc{dceccbe8924c1d,
title = {Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors — Europe PMC PMID:42369076},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42369076},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eccbe8924c1d; sha256 abf1e933d08487ce9d6f5df7c9232720e0b86dbb08f64e7d57ec46ee57913769},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42369076. Agents can read the archived copy with the MCP tool read_document.